Coverage
-
September 30, 2015
The First Circuit told a Massachusetts federal court to rethink blocking a whistleblower from amending his suit alleging a Covidien Ltd. unit got Medicare to illegally fund off-label uses for its blood-blockage device on Wednesday.
1 other articles on this case.
View all »